BTIG Reiterates Buy Rating on Nurix (NRIX)
BTIG analyst Jeet Mukherjee reiterated a Buy rating and $30.00 price target on Nurix (NASDAQ: NRIX).The analyst commented: "NRIX presented ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
